A detailed history of Catalyst Funds Management Pty LTD transactions in Natera, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 18,725 shares of NTRA stock, worth $3.23 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
18,725
Previous 6,700 179.48%
Holding current value
$3.23 Million
Previous $851 Million 248.49%
% of portfolio
0.72%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$117.67 - $174.0 $1.41 Million - $2.09 Million
12,025 Added 179.48%
18,725 $2.96 Billion
Q3 2024

Nov 14, 2024

BUY
$97.75 - $129.67 $654,925 - $868,788
6,700 New
6,700 $851 Million
Q1 2024

Dec 04, 2024

SELL
$59.21 - $92.9 $325,655 - $510,950
-5,500 Reduced 82.09%
1,200 $110 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.